by Jordana Choucair | Jan 19, 2023 | Opioid/Substance Use Disorders
West Virginia State Attorney General Patrick Morrisey announced the state has agreed to an $83 million settlement with Walgreens Boots Alliance Inc. to resolve a lawsuit alleging that the company’s failed control measures contributed to an oversupply of opioids...
by Jordana Choucair | Jan 12, 2023 | Opioid/Substance Use Disorders
New Jersey Attorney General Matthew Platkin announced the state will join a national settlement with several pharmacy chains and drug makers for their roles in the opioid epidemic. The state has signed five agreements with CVS, Walgreens, Walmart, Teva...
by Jordana Choucair | Jan 3, 2023 | Opioid/Substance Use Disorders
The Department of Justice (DOJ) filed a lawsuit against AmerisourceBergen, accusing the company of partially fueling the opioid crisis by failing to report hundreds of thousands of suspicious orders. The lawsuit asks for potentially billions of dollars in financial...
by Jordana Choucair | Dec 19, 2022 | Health IT, Opioid/Substance Use Disorders
Senators Roger Marshall and Jeanne Shaheen plan to introduce legislation that will require social media companies to report fentanyl activity to law enforcement. The legislation would add to House Republicans’ strategy to increase oversight of tech...
by Jordana Choucair | Dec 14, 2022 | Opioid/Substance Use Disorders
The Substance Abuse and Mental Health Services Administration (SAMHSA) released a proposed rule that would make permanent the COVID-19 public health emergency policies that expanded access to opioid addiction medications. The rule would specifically make it easier for...
by Jordana Choucair | Dec 13, 2022 | Opioid/Substance Use Disorders
CVS and Walgreens have agreed to pay a combined $10.7 billion to settle allegations they failed to adequately oversee opioid painkiller prescriptions. CVS will pay $4.9 billion to states and political subdivisions and approximately $130 million to tribes. Walgreens...
Recent Comments